why choose us

First received: September 22, 2022

Clinical Trial: Deucravacitinib Adherence Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Psoriasis

Study Type: INTERVENTIONAL


Official Title: Deucravacitinib Adherence Study

Brief Summary: Psoriasis patients are very poorly adherent to topical treatment.If adherence issues are ignored, poor adherence may limit the real-world efficacy of deucravacitinib, too.Forty psoriasis patients recruited from Wake Forest Baptist Health Dermatology Clinic will be enrolled.Twenty will be randomized to a reporting intervention designed to promote better adherence and the remaining 20 patients will serve as controls who will not receive a reporting intervention.Through qualitative interviews of the 40 patients…

Read more